← Back to Search

Other

Low bicarbonate dialysis for Chronic Kidney Disease

Phase 1
Waitlist Available
Led By Matthew K Abramowitz, MD, MS
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-2 weeks
Awards & highlights
No Placebo-Only Group

Summary

This study will compare acid-base changes during hemodialysis treatments with a standard dialysis bath versus a lower bicarbonate dialysis bath, and aims to define the factors that limit equilibration of the bicarbonate concentration in a patient's blood with that in the dialysate.

Eligible Conditions
  • Acidosis
  • Chronic Kidney Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-2 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in beta-hydroxybutyrate clearance
Change in lactate clearance

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Low bicarbonate dialysisExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Albert Einstein College of MedicineLead Sponsor
296 Previous Clinical Trials
11,689,007 Total Patients Enrolled
Matthew K Abramowitz, MD, MSPrincipal InvestigatorAlbert Einstein College of Medicine
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top